Metabolomic study of disease progression in scrapie prion infected mice; validation of a novel method for brain metabolite extraction
- 12 June 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Metabolomics
- Vol. 16 (6), 1-11
- https://doi.org/10.1007/s11306-020-01690-2
Abstract
Introduction Prion disease is a form of neurodegenerative disease caused by the misfolding and aggregation of cellular prion protein (PrPC). The neurotoxicity of the misfolded form of prion protein, PrPSc still remains understudied. Here we try to investigate this issue using a metabolomics approach. Objectives The intention was to identify and quantify the small-in-size and water-soluble metabolites extracted from mice brains infected with the Rocky Mountain Laboratory isolate of mouse-adapted scrapie prions (RML) and track changes in these metabolites during disease evolution. Methods A total of 73 mice were inoculated with RML prions or normal brain homogenate control; brains were harvested at 30, 60, 90, 120 and 150 days post-inoculation (dpi). We devised a high-efficiency metabolite extraction method and used nuclear magnetic resonance spectroscopy to identify and quantify 50 metabolites in the brain extracts. Data were analyzed using multivariate approach. Results Brain metabolome profiles of RML infected animals displayed continuous changes throughout the course of disease. Among the analyzed metabolites, the most noteworthy changes included increases in myo-inositol and glutamine as well as decreases in 4-aminobutyrate, acetate, aspartate and taurine. Conclusion We report a novel metabolite extraction method for lipid-rich tissue. As all the major metabolites are identifiable and quantifiable by magnetic resonance spectroscopy, this study suggests that tracking of neurochemical profiles could be effective in monitoring the progression of neurodegenerative diseases and useful for assessing the efficacy of candidate therapeutics.Funding Information
- Canadian Institutes of Health Research (MOP137094)
- Canada Foundation for Innovation (NIF21633)
This publication has 30 references indexed in Scilit:
- Alterations in neuronal metabolism contribute to the pathogenesis of prion diseaseCell Death & Differentiation, 2018
- Other Significant MetabolitesPublished by Elsevier BV ,2014
- Combinatorial assessments of brain tissue metabolomics and histopathology in rodent models of human immunodeficiency virus infectionJournal of Neuroimmune Pharmacology, 2013
- Role of Myo-Inositol by Magnetic Resonance Spectroscopy in Early Diagnosis of Alzheimer’s Disease in APP/PS1 Transgenic MiceDementia and Geriatric Cognitive Disorders, 2009
- The Prion's Elusive Reason for BeingAnnual Review of Neuroscience, 2008
- Magnetic resonance spectroscopic analysis of Alzheimer's disease mouse brain that express mutant human APP shows altered neurochemical profileBrain Research, 2004
- A comparison of cell and tissue extraction techniques using high‐resolution 1H‐NMR spectroscopyNMR in Biomedicine, 2002
- Changes in N-acetylaspartate and myo-inositol detected in the cerebral cortex of hamsters with Creutzfeldt-Jakob diseaseMagnetic Resonance Imaging, 1998
- Multinuclear NMR Studies on the Energy Metabolism of Glial and Neuronal CellsDevelopmental Neuroscience, 1993
- In-vivo monitoring of neuronal loss in Creutzfeldt-Jakob disease by proton magnetic resonance spectroscopyThe Lancet, 1991